History & Highlights
History & Highlights
The College of Medicine was established in 1819 and is considered the oldest medical college west of the Allegheny Mountains. As a medical school, we are known for our strong clinical program, student services, and research.
We have an exceptional list of alumni and current and past faculty who have made considerable contributions to medicine and the medical sciences. The University of Cincinnati will give you the resources, the experiences, the insight and the knowledge necessary for you to also make your mark in medicine. How far can you go? Let us take a look at some of our accomplishments.
Leon Goldman, M.D. (class of ’29) opened the first medical laser laboratory in the country and is generally known as the father of Laser Medicine.
Leland C. Clark, Ph.D. developed the heart-lung machine and invented the Clark Oxygen Electrode.
The College of Medicine offered the first residency program in Emergency Medicine.
Albert Sabin, M.D. developed the first oral polio vaccine while on our faculty.
Josef Warkany, M.D., past professor at the College, is regarded as the Father of Teratology (study of birth defects) and his book Congenital Malformations is still considered a medical classic.
Lester Martin, M.D., professor of Surgery and Pediatrics, performed the first successful kidney transplant in Ohio in 1965. He also developed the Lester Martin Operation for total colonic aganglionosis.
Thomas Fogarty, M.D. (class of ‘60) holds over 90 patents for various inventions including the Fogarty Heart Catheter, which is used in most heart surgeries.
Marilyn Gaston, M.D., (class of ’64) the Assistant Surgeon General, is a graduate from the College of Medicine.
George Rieveschl, Jr., Ph.D., Sc.D., is noted for developing the antihistamine, "Benadryl".
Researchers in the Colleges of Engineering and Medicine collaborated to develop a system that identifies leukemia and lymphoma in the earliest stages. The system uses software and computer images to analyze white blood cells.
UC researchers discovered a breakthrough in stroke treatment thanks to a five year NIH funded study. The study revealed that the clot-busting drug TPA can reduce brain damage if given within hours of the stroke.
Imitrex, the first designer drug for treatment of migraines, was partially developed at UC.
Current Developments
Development of a treatment to reduce brain damage in stroke patients.
A nuclear magnetic resonance machine that is so high-tech, it is one of only 15 in the world. We have a facility that is among the top two or three in looking at biomolecular structure and function.
A Women's Reproductive Health Research Scholars program which is one of 12 women's health research centers funded by the National Institute of Child Health and Human Development and the National Institutes of Health.
Recipient of a 12 million dollar National Cancer Institute award to determine if there is a specific gene which increases the risk of developing lung cancer.
Investigation of a gene that controls the growth and death of cells.
Ongoing studies involving variant genes which increase the risk of disease in certain ethnic populations and will assist in better targeting of drug therapies.
Investigation of DNA transmission when cells divide that may cause uncontrolled growth of cells resulting in cancer.
Click
here to learn about research and student opportunities
| 
